Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such inhibitors which are phenylboronic acids I [R1 = N-lower alkyl, (un)substituted (hetero)cyclic alkene] or a pharmaceutically acceptable salt thereof. These compds. may be used with β-lactam antibiotics to treat β-lactam-antibiotic-resistant bacterial infections. Finally, the invention provides a pharmaceutical compn. comprising these compds
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
A method of treating a bacterial infection in a subject in need thereof includes administering to th...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
PCT Int. Appl. (2000), 41 pp. CODEN: PIXXD2 WO 0035904 A1 20000622 CAN 133:53675 AN 2000:421...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
The invention provides a method of treating a .beta.-lactam-antibiotic-resistant bacterial infection...
Worldwide dissemination of pathogens resistant to almost all available antibiotics represent a real ...
Disclosed herein inter alia are Boron containing compounds and methods for treating infections relat...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
A method of treating a bacterial infection in a subject in need thereof includes administering to th...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
PCT Int. Appl. (2000), 41 pp. CODEN: PIXXD2 WO 0035904 A1 20000622 CAN 133:53675 AN 2000:421...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
The invention provides a method of treating a .beta.-lactam-antibiotic-resistant bacterial infection...
Worldwide dissemination of pathogens resistant to almost all available antibiotics represent a real ...
Disclosed herein inter alia are Boron containing compounds and methods for treating infections relat...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
A method of treating a bacterial infection in a subject in need thereof includes administering to th...